Skeletal morbidity in inflammatory bowel disease

Scandinavian Journal of Gastroenterology

Volumn 41, Issue SUPPL. 243, 2006, Pages 59-64

  Van Hogezand, R A ^a   Hamdy, N A T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; GLUCOCORTICOID; OPIATE; BONE DENSITY CONSERVATION AGENT;

BODY MASS; BONE DENSITY; BONE DISEASE; BONE MASS; BONE METABOLISM; CONFERENCE PAPER; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; FRACTURE; HIGH RISK PATIENT; HUMAN; HYPOGONADISM; IMMOBILIZATION; LONG TERM CARE; MALABSORPTION; MALNUTRITION; MINERAL METABOLISM; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; SMOKING; VERTEBRA FRACTURE; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DRUG EFFECT; PREVALENCE; REVIEW; RISK FACTOR; VITAMIN D DEFICIENCY;

BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CROHN DISEASE; DISEASE PROGRESSION; FRACTURES, BONE; GLUCOCORTICOIDS; HUMANS; INFLAMMATORY BOWEL DISEASES; OSTEOPOROSIS; PREVALENCE; RISK FACTORS; VITAMIN D DEFICIENCY;

EID: 33745423077     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600664276     Document Type: Conference Paper

References (79)

1. Andreassen H, Hylander E, Rix M. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients. Am J Gastroenterol 1999;94:824-8.
2. Vogelsang H, Ferenci P, Woloszczuk W, Resch H, Herold C, Frotz S, et al. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 1989;34:1094-9.
3. Driscoll RH, Meredith SC, Sitrin MD, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982;83:1252-8.
4. Picado C, Luengo M. Corticosteroid-induced bone loss: prevention and management. Drug Safety 1996;15:347-59.
5. Rutgeerts PJ. The limitations of corticosteroid therapy in Crohn's disease. Aliment Pharmacol Ther 2001;15:1515-25.
6. Von Tirpitz C, Pischulti G, Klaus J, Rieber A, Bruckel J, Bohm BO, et al. Osteoporosis in patients with inflammatory bowel disease - prevalence and risk factors. Z Gastroenterol 1999;37:5-12.
7. Sambrook P, Raj A, Hunter D, Naganathan V, Mason R, Robinson B. Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. J Rheumatol 2001;28:1063-7.
8. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002;13:777-87.
9. Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995;37:71-6.
10. Stockbrugger RW, Schoon EJ, Bollani S, Mills PR, Israeli E, Landgraf L, et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 2002;16:1519-27.
11. Habtezion A, Silverberg MS, Parkes R, Mikolainis S, Steinhart AH. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 2002;8:87-92.
12. Robinson RJ, Iqbal SJ, Abrams K, Alazzawi F, Mayberry JF. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Therapeut 1998;12:699-705.
13. Bjarnason I, Macpherson A, Mackintosh C, Buxtonthomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228-33.
14. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031-9.
15. Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988;29:1332-6.
16. Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 2000;95:699-704.
17. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998;93:1483-90.
18. Martin A, Fries W, Luisetto G, Mustafa AS, Mussolin L, Plebani M, et al. Bone density and calcium metabolism in patients with long-standing, quiescent Crohn's disease. Eur J Gastroent hepatol 1994;6:611-6.
19. Martin JP, Tonge KA, Bhonsle U, Jacyna MR, Levi J. Bone mineral density in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:537-41.
20. Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995;108:417-22.
21. Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987;28:410-5.
22. Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000;46:176-81.
23. Dear KL, Compston JE, Hunter JO. Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis. Clin Nutr 2001;20:541-6.
24. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995;10:250-6.
25. Motley RJ, Clements D, Evans WD, Crawley EO, Evans C, Rhodes J, et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993;23:95-104.
26. D'Haens G, Verstraete A, Cheyns K, Aerden I, Bouillon R, Rutgeerts P. Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease. Aliment Pharmacol Therapeut 1998;12:419-24.
27. Robinson RJ, Alazzawi F, Iqbal SJ, Kryswcki T, Almond L, Abrams K, et al. Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci 1998;43:2500-6.
28. Clements D, Motley RJ, Evans WD, Harries AD, Rhodes J, Coles RJ, et al. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol 1992;27:1055-60.
29. Staun M, Tjellesen L, Thale M, Schaadt O, Jarnum S. Bone mineral content in patients with Crohn's disease - a longitudinal study in patients with bowel resections. Scand J Gastroenterol 1997;32:226-32.
30. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory dowel disease - a population-based cohort study. Ann Intern Med 2000;133:795-9.
31. Miller PD. Bisphosphonates for the prevention and treatment of corticosteroid-induced osteoporosis. Osteoporos Int 2001;12 Suppl 3:S3-10.
32. Ringe JD, Faber H, Dorst A. Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study. J Clin Endocrinol Metab 2001;86:5252-5.
33. Fries W, Dinca M, Luisetto G, Peccolo F, Bottega F, Martin A. Calcaneal ultrasound bone densitometry in inflammatory bowel disease - a comparison with double X-ray densitometry of the lumbar spine. Am J Gastroenterol 1998;93:2339-44.
34. Pigot F, Roux C, Chaussade S, Hardelin D, Pelleter O, Du Puy Montbrun T, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992;37:1396-403.
35. Robinson RJ, Al-Azzawi F, Iqbal SJ, Abrams K, Mayberry JF. The relation of hand skin-fold thickness to bone mineral density in patients with Crohn's disease. Eur J Gastroenterol Hepatol 1997;9:945-9.
36. Dinca M, Fries W, Luisetto G, Peccolo F, Bottega F, Leone L, et al. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 1999;94:1292-7.
37. Tromm A, Rickels K, Huppe D, Wiebe V, May B. Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography]. [German]. Leber Magen Darm 1994;24:23-30.
38. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998;114:902-11.
39. Klaus J, Armbrecht G, Steinkamp M, Bruckel J, Rieber A, Adler G, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002;51:654-8.
40. Compston J. Osteoporosis in inflammatory bowel disease. Gut 2003;52:63-4.
41. Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrugger RW, Brummer RJM. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 2000;119:1203-8.
42. Vestergaard P, Mosekilde L. Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 2002;156:1-10.
43. Morita M, Saibara T, Nakazawa Y, Miyao M, Okazaki K, Onishi S, et al. A case of Crohn's disease associated with selective IgM deficiency. Nippon Shokakibyo Gakkai Zasshi 1984;81:1070-5.
44. Schulte C, Dignass AU, Mann K, Goebell H. Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study. Scand J Gastroenterol 1999;34:696-702.
45. Teichmann J, Lange U, Stracke H, Doppl W, Klor HU, Federlin K. Rapid spinal trabecular bone loss in female patients with ileitis terminalis Crohn and additional sacroiliac joint inflammation. Rheumatol Int 1997;17:45-8.
46. Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997;40:313-9.
47. Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999;14:1061-6.
48. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-82.
49. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 1999;140:4367-70.
50. Walsh LJ, Lewis SA, Wong CA, Cooper S, Oborne J, Cawte SA, et al. The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med 2002;166:691-5.
51. Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HGM. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacother Drug Safety 2002;9:359-66.
52. Blake GM, Fogelman I. Bone densitometry, steroids and osteoporosis. Curr Opin Nephrol Hypertens 2002;11:641-7.
53. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
54. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 2000;39:1383-9.
55. Reid IR, Veale AG, France JT. Glucocorticoid osteoporosis. J Asthma 1994;31:7-18.
56. Manolagas SC. Corticosteroids and fractures: a close encounter of the third cell kind. J Bone Miner Res 2000;15:1001-5.
57. Kusunoki M, Moeslein G, Shoji Y, Fujita S, Yanagi H, Sakanoue Y, et al. Steroid complications in patients with ulcerative colitis. Dis Colon Rectum 1992;35:1003-9.
58. Cowan FJ, Gregory JW, Jenkins HR. Bone mineral density in Crohn's disease. Gut 1997;41:578-9X.
59. Cowan FJ, Warner JT, Dunstan FJ, Evans WD, Gregory JW, Jenkins HR. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 1997;76:325-9.
60. Schulte C, Dignass AU, Mann K, Goebell H. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 1998;4:268-75.
61. Herzog D, Bishop N, Glorieux F, Seidman EG. Interpretation of bone mineral density values in pediatric Crohn's disease. Inflamm Bowel Dis 1998;4:261-7.
62. Robinson RJ, Iqbal SJ, Wolfe R, Patel K, Abrams K, Mayberry JF. The effect of rectally administered steroids on bone turnover: a comparative study. Aliment Pharmacol Therapeut 1998;12:213-7.
63. Thearle M, Horlick M, Bilezikian JP, Levy J, Gertner JM, Levine LS, et al. Osteoporosis: An unusual presentation of childhood Crohn's disease. J Clin Endocrinol Metab 2000;85:2122-6.
64. Manolagas SC. Role of cytokines in bone resorption. Bone 1995;17 Suppl 2:63S-7S.
65. Reffitt DM, Meenan J, Sanderson JD, Jugdaohsingh R, Powell JJ, Thompson RP. Bone density improves with disease remission in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2003;15:1267-73.
66. Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-terrm oral vitamin D supplementation. Eur J Gastroent Hepatol 1995;7:614.
67. Kull E, Beau P. Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease]. Gastroenterol Clin Biol 2002;26:367-71.
68. van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003;125:1591-7.
69. Card T, West J, Hubbard R, Logan RF. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 2004;53:251-5.
70. Loftus EV Jr, Crowson CS, Sandborn WJ, Tremaine WJ, O'Fallon WM, Melton LJ, III. Long-term fracture risk in patients with Crohn's disease: A population-based study in Olmsted County, Minnesota. Gastroenterology 2002;123:468-75.
71. Cowan FJ, Parker DR, Jenkins HR. Osteopenia in Crohn's disease. Arch Dis Child 1995;73:255-6.
72. Semeao EJ, Stallings VA, Peck SN, Piccoli DA. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology 1997;112:1710-3.
73. Bischoff SC, Herrmann A, Goke M, Manns MP, Vonzurmuhlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997;92:1157-63.
74. Neef B, Horing E, Maier KE, von Gaisberg U. Severe osteoporosis in a young female patient with Crohn's disease. Dtsch Med Wochenschr 1991;116:1055-60.
75. Roux C, Abitbol V, Chaussade S, Kolta S, Guillemant S, Dougados M, et al. Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int 1995;5:156-60.
76. Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, Goodman W, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Therapeut 1996;10:777-86.
77. Cino M, Greenberg GR. Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol 2002;97:915-21.
78. Ulivieri FM, Piodi LP, Taioli E, Lisciandrano D, Ranzi T, Vezzoli M, et al. Bone mineral density and body composition in ulcerative colitis: a six-year follow-up. Osteoporos Int 2000;12:343-8.
79. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol 2004;39:145-53.